Did van Gogh suffer from bipolar mood disorder?

Van Gogh’s last work painted on the morning before he shot himself, is called Tree Roots. Many postulate that this

Can progesterone intervention prevent recurrent miscarriage?

Psychological impact of RPL  The ScreenIVF study found that both partners have a high risk of developing depression and anxiety.

Supplementation in pregnancy: Getting the balance right

Recommended intake of nutrients during pregnancy includes amongst others iron, calcium, and folic acid – each play a role in optimising health outcomes.

Common sense supplementation can prevent bone loss

According to the International Osteoporosis Foundation, 4.28 million fragility fractures occurred in 2019 as a result of bone loss (osteoporosis).

The role of CDK4/6 inhibition in breast cancer

Case vignette In 2013, a 55-year-old female patient presented with a low malignant tumour (T1C N0 M0 grade 3 invasive

Versatile IDegAsp

IDegAsp is a co-formulation of long-acting basal (insulin degludec) and rapid-acting bolus (insulin aspart) insulin (70:30 ratio) and is one

Treating superficial skin infections

Fusidic acid acts by inhibiting bacterial protein synthesis by preventing translocation of the elongation factor G from the ribosome.

Specialist Forum January 2022 CPD

To obtain 3 CPD points, read the associated articles and click on the “start quiz” button to begin.

Acne therapy redesigned

An innovative treatment option for acne vulgaris – combining clindamycin (1%) and tretinoin (0.025%), – was launched in South Africa in November.

Are probiotics the panacea to antibiotic-associated diarrhoea?

Several studies have shown that probiotics improve the microbial balance of the host and reduce colonisation by pathogenic bacteria.

Keys to successful diabetes management in Ramadan

Ramadan is observed by Muslims worldwide as a month of fasting, prayer, reflection, and community. In 2022 the Holy month of Ramadan starts on the evening of 2 April, lasting 30 days and ending at sundown on 1 May.1

Novo Nordisk launches once-weekly semaglutide in South Africa

Once-weekly semaglutide, a human glucagon-like peptide 1 receptor agonist (GLP1-RA), was launched in South Africa on 21 August 2021.